BD Max is believed to be the first and only fully automated, bench-top molecular system designed to perform a broad range of molecular testing. This offers laboratory professionals the flexibility and versatility to perform CE/in vitro diagnostic (IVD) assays and user-defined protocols on the same platform.
The BD Max MRSA and C. diff IVD Assays on the system provide laboratory efficiency to help address the increasing volume of these molecular tests. Rapid and accurate results enable infection control measures to be implemented faster which can positively impact patient management. BD plans to bring new assays to the BD Max system in a broad range of disease categories. The system’s menu and open capability, full automation and standardised workflow, will enable laboratories to consolidate and standardise a broad range of molecular tests to build programs that meet both their current and future clinical needs.
